To resolve charges that its $2.1 billion acquisition of Liberty Dialysis Holdings, Inc. (Liberty) would harm competition in 43 local markets throughout the United States, Fresenius Medical Care AG & Co. KGaA (Fresenius) agreed to divest 60 outpatient dialysis clinics. U.S.-based Liberty is a provider of outpatient dialysis services in the United States, operating 260 dialysis centers in 32 states and the District of
The US FTC settles investigation by requiring divestiture of 60 dialysis clinics (Fresenius / Liberty)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.